Adrelia Allen
Executive Director, Clinical Trial Patient Diversity at Merck
- Role
- Director, Clinical Trial Patient Diversity at Merck
- Location
- Fort Lauderdale, FL, US
- LinkedIn followers
- 500 followers
About Adrelia Allen
Adrelia Allen is an accomplished professional with over two decades of experience in clinical trial operations, strategic planning, and advocacy within the healthcare industry. Currently serving as the Executive Director of Clinical Trial Patient Diversity at Merck, Adrelia leads initiatives aimed at increasing diversity in clinical trials, particularly among communities that have been historically underrepresented in research. Adrelia holds a Doctor of Pharmacy degree from Florida Agricultural & Mechanical University and is a recognized leader in her field, having received honors such as the PharmaVoice 2022 Top 100 in Life Sciences. She is also an active member of professional societies, including the Association of Clinical Research Professionals, where she serves on the Diversity Advisory Council.
Experience
Director, Clinical Trial Patient Diversity
Nov 2020 — Present
Education
Florida Agricultural and Mechanical University
Doctor of Pharmacy (Pharm.D.), Pharmacy
1988 — 1994
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.